Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Diabetes Reviews
  4. Volume 21, Issue 4
  5. Article
Volume 21, Issue 4
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

Type 1 diabetes mellitus (T1D) is a complicated illness marked by the death of insulin-producing pancreatic beta cells, which ultimately leads to insulin insufficiency and hyperglycemia. T lymphocytes are considered to destroy pancreatic beta cells in the etiology of T1D as a result of hereditary and environmental factors. Although the latter factors are very important causes of T1D development, this disease is very genetically predisposed, so there is a significant genetic component to T1D susceptibility. Among the T1D-associated gene mutations, those that affect genes that encode the traditional Human Leukocyte Antigens (HLA) entail the highest risk of T1D development. Accordingly, the results of decades of genetic linkage and association studies clearly demonstrate that mutations in the HLA genes are the most associated mutations with T1D. They can, therefore, be used as biomarkers for prediction strategies and may even prove to be of value for personalized treatments. Other immunity-associated genetic loci are also associated with higher T1D risk. Indeed, T1D is considered an autoimmune disease. Its prevalence is rising globally, especially among children and young people. Given the global rise of, and thus interest in, autoimmune diseases, here we present a short overview of the link between immunity, especially HLA, genes and T1D.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998275617231218101116
2024-01-08
2025-02-17

  • From This Site

    /content/journals/cdr/10.2174/0115733998275617231218101116
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. International diabetes federation - home.Available from: https://idf.org/ (Accessed on 26 oct 2022).
  2. MaahsD.M. WestN.A. LawrenceJ.M. Mayer-DavisE.J. Epidemiology of type 1 diabetes.Endocrinol. Metab. Clin. North Am.201039348149710.1016/j.ecl.2010.05.01120723815
     [Google Scholar]
  3. DerraikJ.G.B. ReedP.W. JefferiesC. CutfieldS.W. HofmanP.L. CutfieldW.S. Increasing incidence and age at diagnosis among children with type 1 diabetes mellitus over a 20-year period in Auckland (New Zealand).PLoS One201272e3264010.1371/journal.pone.003264022389717
     [Google Scholar]
  4. PattersonC.C. DahlquistG.G. GyürüsE. GreenA. SoltészG. EURODIAB Study Group Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: A multicentre prospective registration study.Lancet200937396802027203310.1016/S0140‑6736(09)60568‑719481249
     [Google Scholar]
  5. SnoufferE. An inexplicable upsurge: The rise in type 1 diabetes.Diabetes Res. Clin. Pract.201813724224410.1016/j.diabres.2018.02.02229625722
     [Google Scholar]
  6. RedondoM.J. JeffreyJ. FainP.R. EisenbarthG.S. OrbanT. Concordance for islet autoimmunity among monozygotic twins.N. Engl. J. Med.2008359262849285010.1056/NEJMc080539819109586
     [Google Scholar]
  7. BangarusamyD.K. LakshmananA.P. Al-ZaidanS. AlabduljabbarS. TerranegraA. Nutri-epigenetics: The effect of maternal diet and early nutrition on the pathogenesis of autoimmune diseases.Minerva Pediatr.20217329811010.23736/S2724‑5276.20.06166‑633880901
     [Google Scholar]
  8. Rešić LindehammerS. HonkanenH. NixW.A. OikarinenM. LynchK.F. JönssonI. MarsalK. ObersteS. HyötyH. LernmarkÅ. Seroconversion to islet autoantibodies after enterovirus infection in early pregnancy.Viral Immunol.201225425426110.1089/vim.2012.002222746839
     [Google Scholar]
  9. Sales-PeresS.H de C. GuedesM.F. SáL.M. NegratoC.A. LaurisJ.R. Lifestyle of patients with diabetes mellitus type 1: A systematic review.Cien. Saude Colet.20162141197120610.1590/1413‑81232015214.2024201527076018
     [Google Scholar]
  10. AlessiS.M. FosterN.C. RashC.J. Van NameM.A. TamborlaneW.V. CengizE. PolskyS. WagnerJ. Alcohol use and clinical outcomes in adults in the type 1 diabetes exchange.Can. J. Diabetes202044650150610.1016/j.jcjd.2020.06.00532792103
     [Google Scholar]
  11. Alarcón-GómezJ. Chulvi-MedranoI. Martin-RiveraF. CalatayudJ. Effect of high-intensity interval training on quality of life, sleep quality, exercise motivation and enjoyment in sedentary people with type 1 diabetes mellitus.Int. J. Environ. Res. Public Health202118231261210.3390/ijerph18231261234886337
     [Google Scholar]
  12. SharifK. WatadA. CoplanL. AmitalH. ShoenfeldY. AfekA. Psychological stress and type 1 diabetes mellitus: What is the link?Expert Rev. Clin. Immunol.201814121081108810.1080/1744666X.2018.153878730336709
     [Google Scholar]
  13. AltobelliE. PetrocelliR. VerrottiA. ChiarelliF. MarzilianoC. Genetic and environmental factors affect the onset of type 1 diabetes mellitus.Pediatr. Diabetes201617855956610.1111/pedi.1234526697762
     [Google Scholar]
  14. HandyD.E. CastroR. LoscalzoJ. Epigenetic modifications.Circulation2011123192145215610.1161/CIRCULATIONAHA.110.95683921576679
     [Google Scholar]
  15. StefanM. ZhangW. ConcepcionE. YiZ. TomerY. DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology.J. Autoimmun.201450333710.1016/j.jaut.2013.10.00124210274
     [Google Scholar]
  16. VirolainenS.J. VonHandorfA. VielK.C.M.F. WeirauchM.T. KottyanL.C. Gene–environment interactions and their impact on human health.Genes Immun.202224111110.1038/s41435‑022‑00192‑636585519
     [Google Scholar]
  17. RoepB.O. ThomaidouS. van TienhovenR. ZaldumbideA. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).Nat. Rev. Endocrinol.202117315016110.1038/s41574‑020‑00443‑433293704
     [Google Scholar]
  18. KrogvoldL. SkogO. SundströmG. EdwinB. BuanesT. HanssenK.F. LudvigssonJ. GrabherrM. KorsgrenO. Dahl-JørgensenK. Function of isolated pancreatic islets from patients at onset of type 1 diabetes: insulin secretion can be restored after some days in a nondiabetogenic environment in vitro.Diabetes20156472506251210.2337/db14‑191125677915
     [Google Scholar]
  19. KlinkeD.J.II Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus.PLoS One200831e137410.1371/journal.pone.000137418167535
     [Google Scholar]
  20. MaddaloniE. BolliG.B. FrierB.M. LittleR.R. LeslieR.D. PozzilliP. BuzzettiR. C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.Diabetes Obes. Metab.202224101912192610.1111/dom.1478535676794
     [Google Scholar]
  21. GeptsW. Pathologic anatomy of the pancreas in juvenile diabetes mellitus.Diabetes1965141061963310.2337/diab.14.10.6195318831
     [Google Scholar]
  22. WenzlauJ.M. HuttonJ.C. Novel diabetes autoantibodies and prediction of type 1 diabetes.Curr. Diab. Rep.201313560861510.1007/s11892‑013‑0405‑923900975
     [Google Scholar]
  23. LeiteN.C. PelayoG.C. MeltonD.A. Genetic manipulation of stress pathways can protect stem-cell-derived islets from apoptosis in vitro.Stem Cell Reports202217476677410.1016/j.stemcr.2022.01.01835245439
     [Google Scholar]
  24. Usmani-BrownS. PerdigotoA.L. LavoieN. ClarkP. KorahM. RuiJ. BetancurG. HeroldK.C. β cell responses to inflammation.Mol. Metab.201927Suppl.S104S11310.1016/j.molmet.2019.06.01331500821
     [Google Scholar]
  25. KnipM. VeijolaR. VirtanenS.M. HyötyH. VaaralaO. ÅkerblomH.K. Environmental triggers and determinants of type 1 diabetes.Diabetes200554Suppl. 2S125S13610.2337/diabetes.54.suppl_2.S12516306330
     [Google Scholar]
  26. CoppietersK.T. DottaF. AmirianN. CampbellP.D. KayT.W.H. AtkinsonM.A. RoepB.O. von HerrathM.G. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.J. Exp. Med.20122091516010.1084/jem.2011118722213807
     [Google Scholar]
  27. ItohN. HanafusaT. MiyazakiA. MiyagawaJ. YamagataK. YamamotoK. WaguriM. ImagawaA. TamuraS. InadaM. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.J. Clin. Invest.19939252313232210.1172/JCI1168358227346
     [Google Scholar]
  28. MishraR. ChesiA. CousminerD.L. HawaM.I. BradfieldJ.P. HodgeK.M. GuyV.C. HakonarsonH. MauricioD. SchlootN.C. YderstrædeK.B. VoightB.F. SchwartzS. BoehmB.O. LeslieR.D. GrantS.F.A. Bone Mineral Density in Childhood Study Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes.BMC Med.20171518810.1186/s12916‑017‑0846‑028438156
     [Google Scholar]
  29. TuomiT. GroopL.C. ZimmetP.Z. RowleyM.J. KnowlesW. MackayI.R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.Diabetes199342235936210.2337/diab.42.2.3598425674
     [Google Scholar]
  30. BluestoneJ.A. HeroldK. EisenbarthG. Genetics, pathogenesis and clinical interventions in type 1 diabetes.Nature201046472931293130010.1038/nature0893320432533
     [Google Scholar]
  31. RedondoM.J. YuL. HawaM. MackenzieT. PykeD.A. EisenbarthG.S. LeslieR.D.G. Heterogeneity of Type I diabetes: Analysis of monozygotic twins in Great Britain and the United States.Diabetologia200144335436210.1007/s00125005162611317668
     [Google Scholar]
  32. GiwaA.M. AhmedR. OmidianZ. MajetyN. KarakusK.E. OmerS.M. DonnerT. HamadA.R.A. Current understandings of the pathogenesis of type 1 diabetes: Genetics to environment.World J. Diabetes2020111132510.4239/wjd.v11.i1.1331938470
     [Google Scholar]
  33. Génotypage HLA dans le Consortium international sur la génétique du diabète de type 1 - Josyf C Mychaleckyj, Janelle A Noble, Priscilla V Moonsamy, Joyce A Carlson, Michael D Varney, Jeff Post, Wolfgang Helmberg, June J Pierce, Persia Bonella, Anna Lisa Fear, Eva Lavant , Anthony Louey, Sean Boyle, Julie A Lane, Paul Sali, Samuel Kim, Rebecca Rappner, Dustin T Williams, Letitia H Perdue, David M Reboussin, Brian D Tait, Beena Akolkar, Joan E Hilner, Michael W Steffes, Henry A Erlich , , T1DGC, T1DGC.2010Available from: https://journals.sagepub.com/doi/10.1177/1740774510373494 (Accessed on 26 oct 2022).
  34. BakayM. PandeyR. HakonarsonH. Genes involved in type 1 diabetes: An update.Genes20134349952110.3390/genes403049924705215
     [Google Scholar]
  35. Ounissi-BenkalhaH. PolychronakosC. The molecular genetics of type 1 diabetes: New genes and emerging mechanisms.Trends Mol. Med.200814626827510.1016/j.molmed.2008.04.00218482868
     [Google Scholar]
  36. RamR. MehtaM. NguyenQ.T. LarmaI. BoehmB.O. PociotF. ConcannonP. MorahanG. Systematic evaluation of genes and genetic variants associated with type 1 diabetes susceptibility.J. Immunol.201619673043305310.4049/jimmunol.150205626912320
     [Google Scholar]
  37. SingalD.P. BlajchmanM.A. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus.Diabetes197322642943210.2337/diab.22.6.4294541338
     [Google Scholar]
  38. NobleJ.A. ValdesA.M. Genetics of the HLA region in the prediction of type 1 diabetes.Curr. Diab. Rep.201111653354210.1007/s11892‑011‑0223‑x21912932
     [Google Scholar]
  39. FernandoM.M.A. StevensC.R. WalshE.C. De JagerP.L. GoyetteP. PlengeR.M. VyseT.J. RiouxJ.D. Defining the role of the MHC in autoimmunity: A review and pooled analysis.PLoS Genet.200844e100002410.1371/journal.pgen.100002418437207
     [Google Scholar]
  40. PoolJ.E. HellmannI. JensenJ.D. NielsenR. Population genetic inference from genomic sequence variation.Genome Res.201020329130010.1101/gr.079509.10820067940
     [Google Scholar]
  41. CharlesA. JanewayJ. TraversP. WalportM. ShlomchikM.J. The major histocompatibility complex and its functions. In: Immunobiology: The Immune System in Health and Disease 5th editionGarland Science2001
     [Google Scholar]
  42. BjorkmanP.J. ParhamP. Structure, function, and diversity of class I major histocompatibility complex molecules.Annu. Rev. Biochem.199059125328810.1146/annurev.bi.59.070190.0013452115762
     [Google Scholar]
  43. WieczorekM. AbualrousE.T. StichtJ. Álvaro-BenitoM. StolzenbergS. NoéF. Major histocompatibility complex (MHC) Class I and MHC Class II Proteins: Conformational plasticity in antigen presentation. frontiers in immunology. In: Disponible sur20178 https://www.frontiersin.org/articles/10.3389/fimmu.2017.00292
    [Google Scholar]
  44. PorterRR The polymorphism of the complement genes in HLA.Ann Inst Pasteur Immunol.198513619110110.1016/S0769‑2625(85)80042‑8
     [Google Scholar]
  45. ChooS.Y. The HLA system: Genetics, immunology, clinical testing, and clinical implications.Yonsei Med. J.2007481112310.3349/ymj.2007.48.1.1117326240
     [Google Scholar]
  46. WyattR.C. LanzoniG. RussellM.A. GerlingI. RichardsonS.J. What the HLA-I!—Classical and Non-classical HLA Class I and their potential roles in type 1 diabetes.Curr. Diab. Rep.2019191215910.1007/s11892‑019‑1245‑z31820163
     [Google Scholar]
  47. Cruz-TapiasP. CastiblancoJ. AnayaJ.M. Major histocompatibility complex: Antigen processing and presentation.In: Autoimmunity: From Bench to BedsideEl Rosario University Press2013https://www.ncbi.nlm.nih.gov/books/NBK459467/
     [Google Scholar]
  48. HollingT.M. SchootenE. van Den ElsenP.J. Function and regulation of MHC class II molecules in T-lymphocytes: Of mice and men.Hum. Immunol.200465428229010.1016/j.humimm.2004.01.00515120183
     [Google Scholar]
  49. WijdevenR.H. van LuijnM.M. Wierenga-WolfA.F. AkkermansJ.J. van den ElsenP.J. HintzenR.Q. NeefjesJ. Chemical and genetic control of IFN γ‐induced MHCII expression.EMBO Rep.2018199e4555310.15252/embr.20174555330021835
     [Google Scholar]
  50. HortonR. WilmingL. RandV. LoveringR.C. BrufordE.A. KhodiyarV.K. LushM.J. PoveyS. TalbotC.C.Jr WrightM.W. WainH.M. TrowsdaleJ. ZieglerA. BeckS. Gene map of the extended human MHC.Nat. Rev. Genet.200451288989910.1038/nrg148915573121
     [Google Scholar]
  51. HarisB. AhmedI. SyedN. AlmabraziH. SaraswathiS. Al-KhawagaS. SaeedA. MundekkadanS. MohammedI. SharariS. HawariI. HamedN. AfyouniH. Abdel-KarimT. MohammedS. KhalifaA. Al-MaadheedM. ZyoudM. ShamekhA. ElawwaA. KarimM.Y. Al-KhalafF. Tatari-CalderoneZ. PetrovskiG. HussainK. Clinical features, epidemiology, autoantibody status, HLA haplotypes and genetic mechanisms of type 1 diabetes mellitus among children in Qatar.Sci. Rep.20211111888710.1038/s41598‑021‑98460‑434556755
     [Google Scholar]
  52. SantosD.C. PortoL.C. OliveiraR.V. SeccoD. HanhoerdersterL. PizarroM.H. BarrosB.S.V. MelloL.G.N. MunizL.H. SilvaD.A. GomesM.B. HLA class II genotyping of admixed Brazilian patients with type 1 diabetes according to self-reported color/race in a nationwide study.Sci. Rep.2020101662810.1038/s41598‑020‑63322‑y32313169
     [Google Scholar]
  53. YangJ.K. LinS.S. JiX.J. GuoL.M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.Acta Diabetol.201047319319910.1007/s00592‑009‑0109‑419333547
     [Google Scholar]
  54. GWAS central - studies. Disponible surAvailable from: https://www.gwascentral.org/studies
  55. BradfieldJ.P. QuH.Q. WangK. ZhangH. SleimanP.M. KimC.E. MentchF.D. QiuH. GlessnerJ.T. ThomasK.A. FrackeltonE.C. ChiavacciR.M. ImielinskiM. MonosD.S. PandeyR. BakayM. GrantS.F.A. PolychronakosC. HakonarsonH. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.PLoS Genet.201179e100229310.1371/journal.pgen.100229321980299
     [Google Scholar]
  56. CooperJ.D. HowsonJ.M.M. SmythD. WalkerN.M. StevensH. YangJ.H.M. SheJ.X. EisenbarthG.S. RewersM. ToddJ.A. AkolkarB. ConcannonP. ErlichH.A. JulierC. MorahanG. NerupJ. NierrasC. PociotF. RichS.S. Type 1 Diabetes Genetics Consortium Confirmation of novel type 1 diabetes risk loci in families.Diabetologia2012554996100010.1007/s00125‑012‑2450‑322278338
     [Google Scholar]
  57. QuH-Q. PolychronakosC. The effect of the MHC locus on autoantibodies in type 1 diabetes.J. Med. Genet.200946746947110.1136/jmg.2009.06664719429597
     [Google Scholar]
  58. ZhongH. YangX. KaplanL.M. MolonyC. SchadtE.E. Integrating pathway analysis and genetics of gene expression for genome-wide association studies.Am. J. Hum. Genet.201086458159110.1016/j.ajhg.2010.02.02020346437
     [Google Scholar]
  59. BergholdtR. BrorssonC. PallejaA. BerchtoldL.A. FløyelT. Bang-BerthelsenC.H. FrederiksenK.S. JensenL.J. StørlingJ. PociotF. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression.Diabetes201261495496210.2337/db11‑126322344559
     [Google Scholar]
  60. BoyleE.A. LiY.I. PritchardJ.K. An expanded view of complex traits: From polygenic to omnigenic.Cell201716971177118610.1016/j.cell.2017.05.03828622505
     [Google Scholar]
  61. ChenJ. TianW. Explaining the disease phenotype of intergenic SNP through predicted long range regulation.Nucleic Acids Res.201644188641865410.1093/nar/gkw51927280978
     [Google Scholar]
  62. FadasonT. EkbladC. IngramJ.R. SchierdingW.S. O’SullivanJ.M. Physical interactions and expression quantitative traits loci identify regulatory connections for obesity and type 2 diabetes associated snps. In: Frontiers in Genetics20178
     [Google Scholar]
  63. FarhK.K.H. MarsonA. ZhuJ. KleinewietfeldM. HousleyW.J. BeikS. ShoreshN. WhittonH. RyanR.J.H. ShishkinA.A. HatanM. Carrasco-AlfonsoM.J. MayerD. LuckeyC.J. PatsopoulosN.A. De JagerP.L. KuchrooV.K. EpsteinC.B. DalyM.J. HaflerD.A. BernsteinB.E. Genetic and epigenetic fine mapping of causal autoimmune disease variants.Nature2015518753933734310.1038/nature1383525363779
     [Google Scholar]
  64. RamR. MorahanG. Effects of Type 1 diabetes risk alleles on immune cell gene expression.Genes20178616710.3390/genes806016728635624
     [Google Scholar]
  65. JavierreB.M. BurrenO.S. WilderS.P. KreuzhuberR. HillS.M. SewitzS. CairnsJ. WingettS.W. VárnaiC. ThieckeM.J. BurdenF. FarrowS. CutlerA.J. RehnströmK. DownesK. GrassiL. KostadimaM. Freire-PritchettP. WangF. StunnenbergH.G. ToddJ.A. ZerbinoD.R. StegleO. OuwehandW.H. FrontiniM. WallaceC. SpivakovM. FraserP. MartensJ.H. KimB. SharifiN. Janssen-MegensE.M. YaspoM-L. LinserM. KovacsovicsA. ClarkeL. RichardsonD. DattaA. FlicekP. BLUEPRINT Consortium Lineage-specific genome architecture links enhancers and non-coding disease variants to target gene promoters.Cell2016167513691384.e1910.1016/j.cell.2016.09.03727863249
     [Google Scholar]
  66. BoatengD. AyellahB.B. AdjeiD.N. AgyemangC. Contribution of diabetes to amputations in sub-Sahara Africa: A systematic review and meta-analysis.Prim. Care Diabetes202216334134910.1016/j.pcd.2022.01.01135305899
     [Google Scholar]
  67. Lorenzo-AlmorósA. Cepeda-RodrigoJ.M. LorenzoÓ. Diabetic cardiomyopathy.Rev. Clin. Esp.2022222210011110.1016/j.rceng.2019.10.01235115137
     [Google Scholar]
  68. KimD.S. SchererP.E. Obesity, diabetes, and increased cancer progression.Diabetes Metab. J.202145679981210.4093/dmj.2021.007734847640
     [Google Scholar]
  69. HughesJ.W. RiddlesworthT.D. DiMeglioL.A. MillerK.M. RickelsM.R. McGillJ.B. T1D Exchange Clinic Network Autoimmune diseases in children and adults with type 1 diabetes from the T1D exchange clinic registry.J. Clin. Endocrinol. Metab.2016101124931493710.1210/jc.2016‑247827676394
     [Google Scholar]
  70. ConcannonP. RichS.S. NepomG.T. Genetics of type 1A diabetes.N. Engl. J. Med.2009360161646165410.1056/NEJMra080828419369670
     [Google Scholar]
  71. Brooks-WorrellB. NarlaR. PalmerJ.P. Biomarkers and immune-modulating therapies for Type 2 diabetes.Trends Immunol.2012331154655310.1016/j.it.2012.07.00222897868
     [Google Scholar]
  72. KatsarouA. GudbjörnsdottirS. RawshaniA. DabeleaD. BonifacioE. AndersonB.J. JacobsenL.M. SchatzD.A. LernmarkÅ. Type 1 diabetes mellitus.Nat. Rev. Dis. Primers2017311701610.1038/nrdp.2017.1628358037
     [Google Scholar]
  73. MacDonaldP.E. RorsmanP. Oscillations, intercellular coupling, and insulin secretion in pancreatic β cells.PLoS Biol.200642e4910.1371/journal.pbio.004004916464129
     [Google Scholar]
  74. BarrettJ.C. ClaytonD.G. ConcannonP. AkolkarB. CooperJ.D. ErlichH.A. JulierC. MorahanG. NerupJ. NierrasC. PlagnolV. PociotF. SchuilenburgH. SmythD.J. StevensH. ToddJ.A. WalkerN.M. RichS.S. Type 1 Diabetes Genetics Consortium Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.Nat. Genet.200941670370710.1038/ng.38119430480
     [Google Scholar]
  75. NobleJ.A. ErlichH.A. Genetics of type 1 diabetes.Cold Spring Harb. Perspect. Med.201221a00773210.1101/cshperspect.a00773222315720
     [Google Scholar]
  76. ToddJ.A. WalkerN.M. CooperJ.D. SmythD.J. DownesK. PlagnolV. BaileyR. NejentsevS. FieldS.F. PayneF. LoweC.E. SzeszkoJ.S. HaflerJ.P. ZeitelsL. YangJ.H.M. VellaA. NutlandS. StevensH.E. SchuilenburgH. ColemanG. MaisuriaM. MeadowsW. SminkL.J. HealyB. BurrenO.S. LamA.A.C. OvingtonN.R. AllenJ. AdlemE. LeungH.T. WallaceC. HowsonJ.M.M. GujaC. Ionescu-TîrgovişteC. SimmondsM.J. HewardJ.M. GoughS.C.L. DungerD.B. WickerL.S. ClaytonD.G. Genetics of Type 1 Diabetes in Finland Wellcome Trust Case Control Consortium Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.Nat. Genet.200739785786410.1038/ng206817554260
     [Google Scholar]
  77. Evidence of association with type 1 diabetes in the SLC11A1 gene region | BMC medical genetics | full text.Available from: https://bmcmedgenet.biomedcentral.com/articles/10.1186/1471-2350-12-59
  78. SmythD.J. PlagnolV. WalkerN.M. CooperJ.D. DownesK. YangJ.H.M. HowsonJ.M.M. StevensH. McManusR. WijmengaC. HeapG.A. DuboisP.C. ClaytonD.G. HuntK.A. van HeelD.A. ToddJ.A. Shared and distinct genetic variants in type 1 diabetes and celiac disease.N. Engl. J. Med.2008359262767277710.1056/NEJMoa080791719073967
     [Google Scholar]
  79. Onengut-GumuscuS. ChenW.M. BurrenO. CooperN.J. QuinlanA.R. MychaleckyjJ.C. FarberE. BonnieJ.K. SzpakM. SchofieldE. AchuthanP. GuoH. FortuneM.D. StevensH. WalkerN.M. WardL.D. KundajeA. KellisM. DalyM.J. BarrettJ.C. CooperJ.D. DeloukasP. ToddJ.A. WallaceC. ConcannonP. RichS.S. Type 1 Diabetes Genetics Consortium Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.Nat. Genet.201547438138610.1038/ng.324525751624
     [Google Scholar]
  80. BaschalE.E. SarkarS.A. BoyleT.A. SiebertJ.C. JasinskiJ.M. GrabekK.R. ArmstrongT.K. BabuS.R. FainP.R. SteckA.K. RewersM.J. EisenbarthG.S. Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex.J. Diabetes20113323824710.1111/j.1753‑0407.2011.00131.x21631897
     [Google Scholar]
  81. ForbesJ.M. SöderlundJ. YapF.Y.T. KnipM. AndrikopoulosS. IlonenJ. SimellO. VeijolaR. SourrisK.C. CoughlanM.T. ForsblomC. SlatteryR. GreyS.T. WessmanM. YamamotoH. BierhausA. CooperM.E. GroopP.H. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes.Diabetologia20115451032104210.1007/s00125‑011‑2058‑z21298413
     [Google Scholar]
  82. SwaffordA.D.E. HowsonJ.M.M. DavisonL.J. WallaceC. SmythD.J. SchuilenburgH. Maisuria-ArmerM. MistryT. LenardoM.J. ToddJ.A. An allele of IKZF1 (Ikaros) conferring susceptibility to childhood acute lymphoblastic leukemia protects against type 1 diabetes.Diabetes20116031041104410.2337/db10‑044621270240
     [Google Scholar]
  83. HuangJ. EllinghausD. FrankeA. HowieB. LiY. 1000 Genomes-based imputation identifies novel and refined associations for the wellcome trust case control consortium phase 1 data.Eur. J. Hum. Genet.201220780180510.1038/ejhg.2012.322293688
     [Google Scholar]
  84. SmythD.J. CooperJ.D. HowsonJ.M.M. ClarkeP. DownesK. MistryT. StevensH. WalkerN.M. ToddJ.A. FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection.Diabetes201160113081308410.2337/db11‑063822025780
     [Google Scholar]
/content/journals/cdr/10.2174/0115733998275617231218101116
Loading
Association of the Immunity Genes with Type 1 Diabetes Mellitus
Curr. Diabetes Rev. 21, E080124225347 (2025); https://doi.org/10.2174/0115733998275617231218101116
/content/journals/cdr/10.2174/0115733998275617231218101116
/content/journals/cdr/10.2174/0115733998275617231218101116
Loading

Data & Media loading...

Supplements

A supplementary Table displaying the polymorphisms within the human genome linked to type 1 diabetes (data sourced from reference [34]). The information on Single Nucleotide Polymorphisms (SNPs) has been connected to T1D through genome-wide association studies (GWAS) and meta-analyses.

file format download Download

  • Article Type:     Review Article
Keyword(s): beta-cell autoimmunity; gene; GWAS; HLA; SNPs; Type 1 diabetes

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test